Skip to main content

We offer one of the most comprehensive pharmacogenomics test panels available

Quest Diagnostics offers one of the most comprehensive pharmacogenomics test panels available to help you gain insight into a patient’s potential response to medications and optimize their treatment considerations and outcomes. This includes information for over 40 genes, but does not provide information about specific drugs or drug classes. This full panel is particularly advantageous for patients on multiple medications who may otherwise require multiple panels—all at a low cost and coming from a company you trust to meet all of your lab needs.

The Pharmacogenomics Panel from Quest provides pharmacogenetic information for over 40 genes.  

Physicians receive test results in a comprehensive and easy to understand report. Results can be utilized as a reference for your patients throughout their lifetime.

Why Pharmacogenomics

Pharmacogenetics/pharmacogenomics (PGx) is the study of how inherited genetic differences impact the way drugs or medications affect a person. These genetic differences can impact the way a drug is absorbed or metabolized and thereby influence drug response. Pharmacogenomic tests may provide information about a person’s genetic makeup to help doctors decide which medications and doses might work best for him or her. Pharmacogenomic testing can also help reduce the time and costs associated with a trial-and-error approach to treatment.1

Avoiding adverse drug reactions can make a difference

3million

adverse drug reactions annually2

 

1million

Er visits due to adverse drug reactions3

100,000

fatalities due to adverse drug reactions4

The power of pharmacogenomics

The Pharmacogenomics Panel from Quest provides pharmacogenetic information for over 40 genes, which can be used by the physician to assess:


  • Risk of adverse drug reaction
  • Efficacy (i.e., will it work?)

Consider ordering a Pharmacogenomics Panel:

  • Prior to starting a specific drug therapy with common significant adverse effects
  • If a person has started taking a drug and is experiencing side effects
  • If a clinician is having trouble establishing and/or maintaining a stable dose of a drug
  • For patients on multiple medications

Ordering Information

View our step-by-step process on how to order a pharmacogenomic panel.

How to order

Supporting your patients

Quest Diagnostics wants to make sure as many patients as possible can take advantage of the benefits of pharmacogenomics testing.

  • We are in network with most major insurance companies
  • We offer financial assistance to patients who qualify
  • We have more than 2,200 Patient Service Centers across the US

STAY IN TOUCH

Take advantage of the benefits of pharmacogenomics initiatives

Fill out our short form and submit to receive communications from Quest Diagnostics on Pharmacogenomics and related content.

References

  1. Elliott LS, Henderson JC, Neradilek MB, Moyer NA, Ashcraft KC, Thirumaran RK. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: a prospective pilot randomized controlled trial. PLoS One. 2017;12(2):e0170905. doi: 10.1371/journal.pone.0170905
  2. US Food & Drug Administration (FDA). Preventable adverse drug reactions: a focus on drug interactions. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm110632.htm. Updated March 6, 2018. Accessed December 4, 2018.
  3. Office of Disease Prevention and Health Promotion. Adverse drug events overview. https://health.gov/hcq/ade.asp. Updated December 7, 2017. Accessed December 4, 2018.
  4. Personalized Medicine Project. Section 1: basics of personalized medicine. http://personalizedmedicineproject.weebly.com/section-1-basics-of-personalized-medicine.html. Accessed December 4, 2018.

Contact us

Call 1.866.GENE.INFO (1.866.436.3463) or email GeneInfo@QuestDiagnostics.com today for information about any of the solutions above. If calling from outside the US call 1.678.406.1198.